Phase II Trial of Gleevec [imatinib] (Formerly Known as STI571) in Patients With Soft Tissue and Bone Sarcomas: A Multi-Disciplinary Trial of the North American Sarcoma Study Group of the Connective Tissue Oncology Society
Latest Information Update: 22 Jun 2013
At a glance
- Drugs Imatinib (Primary)
- Indications Ewing's sarcoma; Haemangiosarcoma; Liposarcoma; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Soft tissue sarcoma
- Focus Therapeutic Use
- 16 May 2007 Status changed from in progress to completed
- 24 Sep 2005 New trial record.